MRC1 and cancer: Universal IHC screening for LS can also assist with genetic assessment and testing of both MMR-screen-positive and screen-negative individuals with a high suspicion of an inherited cancer syndrome by helping to direct whether testing should be restricted to MMR genes versus a larger panel encompassing other cancer predisposition genes.